David Gentien

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès et al. · The Lancet Oncology · 2015 · 1.1K citations

Advanced Cancer, Drug Targeting, Oncology +12

<i>SF3B1</i> Mutations Are Associated with Alternative Splicing in Uveal Melanoma

Simon J. Furney, Malin Pedersen, David Gentien et al. · Cancer Discovery · 2013 · 422 citations · Full text

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)

Fabrice André, Thomas Bachelot, Frédéric Commo et al. · The Lancet Oncology · 2014 · 400 citations

Dna Sequencing, Metastatic Breast Cancer, Breast Oncology +11

Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges

Barbara Piasecka, Darragh Duffy, Alejandra Urrutia et al. · Proceedings of the National Academy of Sciences · 2017 · 229 citations · Full text

A gene-expression profiling score for prediction of outcome in patients with follicular lymphoma: a retrospective training and validation analysis in three international cohorts

Sarah Huet, Bruno Tesson, Jean‐Philippe Jais et al. · The Lancet Oncology · 2018 · 217 citations · Full text

Lymphoid Neoplasia, Oncology, Medicine +12